Mesothelioma Attorneys: A Brief Overview
Mesothelioma cancer affects the protective lining that surrounds vital internal organs like the heart, lung and abdomen. It is treatable but is not curable. The most common cause of this malignant cancer is exposure to harmful asbestos fibers, usually – but not always – over a considerable period of time. People who work for cement or brick manufacturers, fire and pipe insulator manufacturers, or any others who use asbestos are potentially at a higher risk to develop this disease. Proper safety precautions around the harmful fibers are not always used, or – in some cases – workers are not even informed of the potential dangers inherent in the materials being handled. It is because of such negligence, in many cases, that workers went on to develop this often fatal disease.
Mesothelioma Attorneys: A Brief Overview
Mesothelioma cancer affects the protective lining that surrounds vital internal organs like the heart, lung and abdomen. It is treatable but is not curable. The most common cause of this malignant cancer is exposure to harmful asbestos fibers, usually – but not always – over a considerable period of time. People who work for cement or brick manufacturers, fire and pipe insulator manufacturers, or any others who use asbestos are potentially at a higher risk to develop this disease. Proper safety precautions around the harmful fibers are not always used, or – in some cases – workers are not even informed of the potential dangers inherent in the materials being handled. It is because of such negligence, in many cases, that workers went on to develop this often fatal disease.
Mesothelioma Prognosis – Get Straight Facts
The word meaning of the term prognosis is outcome. It is important when it is spoken together with mesothelioma. Mesothelioma prognosis can be tough for some of the patients. After all those years serving the industry, when the patient realizes that they are swindled ultimately, the desperation and pain can proliferate in the sadness. Some of the doctors will conclude the truth that the prospects of survival are slim. The rest of the ensemble inspires hope into the mind of the patient. The outcome of mesothelioma depends on how the body is responding to the treatment.
More Information Regarding Mesothelioma Attorneys
What is mesothelioma?
Mesothelioma is a malignant form of cancer that develops in the protective lining (mesothelium) that covers most internal organs in human body. The most common sites in the body affected by this disease are the pleura, the outer lining of the lung, and the pericardium, the sac that surrounds the heart. People who have been exposed to asbestos in the workplace for a prolonged period of time can be at greater risk of contracting the disease.
How can mesothelioma attorneys help victims?
What Makes a Mesothelioma Lawyer?
Mesothelioma is the cancer of the inner lining of the abdominal organs of the human body. It is an aggressive and malicious disease that does not take long to spread to other parts of the body, wreaking havoc in its path. Medical research has found that there may be a definitive link between this fatal cancer and exposure to asbestos. Until the late 1970s, this type of cancer was extremely rare and few people actually knew much about the various probable health risks associated with asbestos. As a result, asbestos was used in hundreds of products throughout the 20th century and thousands of workers were exposed to this dangerous material without proper protection. As the cases of people diagnosed with cancer of the Mesothelium increased, new research was conducted, which proved that people who have been exposed to asbestos dust and fibers may be at a greater risk of contracting this disease.Mesothelioma lawyers are best equipped to assist in filing a lawsuit against the manufacturers who failed to take adequate safety measures to protect workers from exposure to asbestos.
Mesothelioma: The Working Man’s Killer
Back in the day, asbestos was used in the construction of many buildings and places of business. Unknowing workers worked in these structures each day not know that there was danger lurking in the walls and ceiling. Some years later, they were diagnosed with a type of lung cancer that was directly attributed to the asbestos exposure. Luckily today, asbestos is no longer used as a building material due to the risk.
Mesothelioma And Bidimensionally Measureable Lesions
Another interesting study is called, Modified RECIST criteria for assessment of response in malignant pleural Mesothelioma by M. J. Byrne and A. K. Nowak – Ann Oncol (2004) 15 (2): 257-260. Here is an excerpt: Abstract – Background: The growth pattern of malignant pleural mesothelioma makes the use of RECIST (response evaluation criteria in solid tumours) response criteria difficult. We have developed and validated Modified RECIST criteria adapted to the growth pattern of malignant pleural mesothelioma. Patients and methods: We evaluated 73 patients from two clinical trials of cisplatin/gemcitabine chemotherapy in malignant pleural mesothelioma. Tumour thickness perpendicular to the chest wall or mediastinum was measured in two positions at three separate levels on thoracic CT scans. The sum of the six measurements defined a pleural unidimensional measure. Bidimensionally measureable lesions were measured unidimensionally as for RECIST. All measurements were added to obtain the total tumour measurement. A reduction of at least 30% on two occasions 4 weeks apart defined a partial response; an increase of 20% over the nadir measurement, progressive disease. The validity of the modified criteria was gauged by evaluating survival and pulmonary function. Results: Response according to these criteria predicted for superior survival (15.1 versus 8.9 months; P = 0.03) and forced vital capacity (FVC) increase during treatment (P
Mesothelioma: Why you deserve compensation
The subject matter, Mesothelioma: Why you deserve compensation, is paramount. “According to Wikipedia, the first lawsuits against asbestos manufacturers were in 1929. Since then, many lawsuits have been filed against asbestos manufacturers and employers, for neglecting to implement safety measures after the links between asbestos, asbestosis, and mesothelioma became known (some reports seem to place this as early as 1898). The liability resulting from the sheer number of lawsuits and people affected has reached billions of dollars.[46] The amounts and method of allocating compensation have been the source of many court cases, reaching up to the United States Supreme Court, and government attempts at resolution of existing and future cases. However, to date, the US Congress has not stepped in and there are no federal laws governing asbestos compensation.”
Unresectable Pleural And Peritoneal Mesothelioma Research
Another interesting study is called, Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B – Clinical Cancer Research March 2005 11; 2300 by Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon II, Gloria A. Niehans, Robin Vollmer, Dorothy Watson, Mark R. Green, Hedy L. Kindler and on behalf of the Cancer and Leukemia Group B. Here is an excerpt: Abstract – Purpose: The Cancer and Leukemia Group B conducted a phase II study of gefitinib, an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, in patients with previously untreated malignant mesothelioma. Experimental Design: Eligible patients had unresectable pleural or peritoneal mesothelioma, measurable disease, no prior therapy, and performance status 0-1 by Cancer and Leukemia Group B criteria. Gefitinib (500 mg p.o.) was administered once a day for 21 days. Patients underwent restaging after every two cycles. Therapy was continued until disease progression or unacceptable toxicity. Results: The most common grade 3 toxicities were diarrhea (16%) and nausea (12%). Of 43 patients enrolled, 1 patient (2%) had a complete response, 1 patient (2%) had a partial response, 21 (49%) had stable disease lasting two to eight cycles, 15 (35%) had progressive disease, and 5 (12%) had early deaths. One-year survival was 32% [95% confidence interval (CI), 21-50%]. Median survival and failure-free survival were 6.8% (95% CI, 3.5-10.3) and 2.6 months (95% CI, 1.5-4.0), respectively. The 3-month failure-free survival was 40% (95% CI, 25-56%). EGFR expression score by immunohistochemistry done in 28 patients was categorized as low (EGFR 1+ or 2+) or high (EGFR 3+) expression: 97% had EGFR overexpression (2+ or 3+). The median and 3-month failure-free survival were 3.6 months and 40% for those patients with low EGFR expression compared with 8.1 and 40% for those with high EGFR expression.
Mesothelioma A Deadly Asbestos Cancer
Mesothelioma is a rare type of cancer who’s only known cause is asbestos exposure. Although the cancer is not common in the general population, people who have worked around asbestos frequently develop mesothelioma after inhaling or swallowing asbestos fibres. The disease, which can remain hidden for years, most often develops in the lining surrounding the lungs called the Mesothelium. Exposure to asbestos for prolonged periods in workplaces such as construction, military and industrial sites can result in mesothelioma decades later. It is also possible for workers to bring asbestos home on their clothes or body, exposing people in their household to the dangerous substance.